Guided Therapeutics, Konica Minolta extend product licensing agreement for third year

Guided Therapeutics LuViva Advanced Cervical Scan biophotonic testing platform

For a third consecutive year, Guided Therapeutics (Norcross, GA) has extended its licensing agreement with Konica Minolta (Tokyo, Japan) to co-develop a noninvasive biophotonic testing platform for early detection of Barrett's esophagus, which can precede esophageal cancer.

Under the terms of the agreement, Guided Therapeutics will be paid approximately $2 million, including a licensing fee over the course of the next eight months, subject to certain milestones, by Konica Minolta Technology Center. As part of the focus in the coming year to develop a product for detection of esophageal cancer, Guided Therapeutics will retain all rights to lung and biliary cancer that were previously shared.

The Barrett’s esophagus product being developed with Konica Minolta is based on the company’s noninvasive cervical disease detection technology, the LuViva Advanced Cervical Scan, which is undergoing FDA premarket approval and CE Mark review.

Mark L. Faupel, Ph.D., Guided Therapeutics' president and CEO, notes that the results of the company's recently completed feasibility study should lead to a larger patient multicenter clinical study in the near future.


Follow us on Twitter, 'like' us on Facebook, and join our group on LinkedIn

Follow Laser Focus World on your iPhone or Android

Subscribe now to BioOptics World magazine; it's free!

Get All the BioOptics World News Delivered to Your Inbox

Subscribe to BioOptics World Magazine or email newsletter today at no cost and receive the latest news and information.

 Subscribe Now
Related Articles

Cynosure earns FDA clearance for at-home wrinkle treatment device

Cynosure (NASDAQ: CYNO) has received FDA clearance to market a home-use, over-the-counter device for treating facial wrinkles.

Global biophotonics market should exceed $99B by 2018, says GIA

Global Industry Analysts (GIA) recently released a global report on biophotonics markets, forecasting them to exceed $99 billion by the year 2018.

TeraView earns MHRA approval to conduct in-vivo clinical trials for cancer imaging

Terahertz solutions and technology manufacturer TeraView has received approval by the Medicines and Healthcare products Regulatory Agency (MHRA) to conduct in-vivo clinical trials for cancer resear...

Carl Zeiss, Olympus enter licensing agreement for digital pathology patents

Carl Zeiss Microscopy and Olympus America have entered into a nonexclusive worldwide licensing agreement that allows Carl Zeiss to access an extensive portfolio of patents held by Olympus in digita...


Neuro15 exhibitors meet exacting demands: Part 2

Increasingly, neuroscientists are working with researchers in disciplines such as chemistry and p...

Why be free?

A successful career contributed to keeping OpticalRayTracer—an optical design software program—fr...

LASER Munich 2015 is bio-bent

LASER World of Photonics 2015 included the European Conferences on Biomedical Optics among its si...

White Papers

Understanding Optical Filters

Optical filters can be used to attenuate or enhance an image, transmit or reflect specific wavele...

How can I find the right digital camera for my microscopy application?

Nowadays, image processing is found in a wide range of optical microscopy applications. Examples ...



Twitter- BioOptics World

Copyright © 2007-2016. PennWell Corporation, Tulsa, OK. All Rights Reserved.PRIVACY POLICY | TERMS AND CONDITIONS